Physician profile
Robert Clinton
NPI 1235222928
$1,336.12
in general payments reported to CMS, 2019-2025
12 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.86 · 2020: $16.28 · 2021: $362 · 2023: $135 · 2024: $374 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $216 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $215.55 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $307.00 | 2021 | |
| Abbvie INC. | $215.55 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $204.58 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $145.15 | 2024-2025 | Uzedy |
| Alkermes, INC. | $112.60 | 2024-2025 | Aristada, Lybalvi, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $108.11 | 2024-2025 | Rexulti, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $76.60 | 2025 | Hetlioz, Fanapt |
| Genentech USA, INC. | $67.06 | 2019-2021 | |
| Phadia US INC. | $36.48 | 2019 | |
| Glaxosmithkline, LLC. | $24.26 | 2019 | |
| Neurocrine Biosciences, INC. | $22.45 | 2024 | Ingrezza |
| Lilly USA, LLC | $16.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.